Archon Biosciences
Washington
About Archon Biosciences
Archon is a biotechnology firm that creates computationally engineered proteins to unleash potent therapeutic targets beyond the grasp of current methods and improve disease management.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $20.0M
- Funding stage: Seed
- Last round: Seed (Oct 2024)
- Website: archon.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/archon-biosciences-121298 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.